Stock QGEN QIAGEN N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Qiagen N.V.

Equities

QGEN

NL0015001WM6

Biotechnology & Medical Research

Market Closed - Nyse
Other stock markets
 04:00:02 2024-12-11 pm EST 		Pre-market 07:58:50 am
46.16 USD +0.20% Intraday chart for Qiagen N.V. 45.98 -0.38%
Dec. 05 Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally MT
Dec. 05 Qiagen N.V. Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-05-2024 10:50 AM

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
Dec. 05
 BU
QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
Nov. 28
 BU
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Nov. 27
 AQ
Qiagen N : Citi’s Global Healthcare Conference Investor Introduction
Nov. 26
 PU
Qiagen N : Wolfe Research Healthcare Conference 2024 Investor Introduction
Nov. 15
 PU
QIAGEN collaborates with McGill University to advance microbiome research
Nov. 12
 AQ
Qiagen N : Third Quarter 2024 SEC Filing
Nov. 08
 PU
Qiagen N : U.S. GAAP Quarterly Report for the Period Ended September 30, 2024 Form 6 K
Nov. 08
 PU
Qiagen N : delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook Form 6 K
Nov. 08
 PU
Q3 2024 Results Conference Call Presentation: Thursday, November 7, 2024
Nov. 07
 PU
Qiagen N : QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full year 2024 adjusted EPS outlook
Nov. 07
 PU
Qiagen: Q3 Earnings Snapshot
Nov. 06
 AQ
Q3 2024 Results Press Release: Wednesday, November 6, 2024
Nov. 06
 PU
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
Nov. 06
 AQ
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Nov. 04
 AQ
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Oct. 29
 AQ
Qiagen N : Digital Insights launches PGXI knowledgebase to enable access to expert-curated pharmacogenomic insights
Oct. 22
 PU
QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
Oct. 10
 AQ
QIAGEN N.V. to release results for Q3 2024 and hold webcast
Oct. 10
 AQ
Q3 2024 Results Webcast Dial in details: Thursday, November 7, 2024
Oct. 10
 PU
Qiagen N : Digital Insights Expands Biopharma Collaboration with Neo4j to advance Biomedical Data Analysis
Oct. 08
 PU
Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
Oct. 07
 AQ
Qiagen N : VENLO
Sep. 30
 PU
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
Sep. 30
 AQ
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
Sep. 26
 AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. News Qiagen N.V.
  5. Press Releases